Work

Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis

Year: 2023

Type: erratum

Abstract: A number of minor errors were introduced in the online ahead-of-print version of this article, as summarized below.These errors are corrected in the published version.On page 1, a company name was changed from using an ampersand to the word ''and.''The correct company name uses an ampersand: OPEN Health Evidence & Access.On page 1, in the Results section of the Abstract, a space was inserted between the negative symbol and 2.0 in ''[-2.0 to 16.7].''In the graphical abstract on page 2, ''anti-tumor'' was changed to ''anti!tumor'' and will be amended in the figure.

Source: Dermatology and Therapy

DOI: 10.1007/s13555-023-01043-6